Veracyte (VCYT) Cash from Investing Activities (2012 - 2026)
Veracyte (VCYT) posted Cash from Investing Activities of -$128.0 million for Q1 2026, down 2256.56% sequentially from -$5.4 million in Q4 2025, and down 146.94% YoY from $272.6 million in Q1 2025.
Veracyte (VCYT) Cash from Investing Activities (2012 - 2026) Analysis & Trends
Veracyte (VCYT) has 15 years of Cash from Investing Activities data on file, last reported at -$128.0 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 146.94% year-over-year to -$128.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$85.4 million (up 23.09% YoY) and the FY2025 annual result came in at -$9.2 million, up 83.64% from the prior year.
- Cash from Investing Activities declined to -$128.0 million in Q1 2026 per VCYT's latest filing, from -$5.4 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $48.3 million in Q3 2025, with the low at -$128.0 million in Q1 2026.
- Average Cash from Investing Activities over 5 years is -$12.2 million, with a median of -$2.8 million recorded in 2024.
- Year-over-year, Cash from Investing Activities plunged 6965.97% in 2022 and soared 2252.68% in 2025.
- Veracyte's Cash from Investing Activities stood at -$26.4 million in 2022, then jumped by 90.55% to -$2.5 million in 2023, then slumped by 2068.24% to -$54.1 million in 2024, then surged by 89.97% to -$5.4 million in 2025, then sank by 2256.56% to -$128.0 million in 2026.
- Business Quant data shows VCYT's Cash from Investing Activities at -$128.0 million in Q1 2026, -$5.4 million in Q4 2025, and $48.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn | -127.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.96 Mn |
| Mar 31, 2026 | -127.96 Mn |
| Dec 31, 2025 | -5.43 Mn |
| Dec 31, 2025 | -5.43 Mn |
| Sep 30, 2025 | 48.26 Mn |
| Sep 30, 2025 | 48.26 Mn |
| Jun 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Mar 31, 2025 | -51.82 Mn |
| Mar 31, 2025 | -51.82 Mn |
| Dec 31, 2024 | -54.14 Mn |
| Dec 31, 2024 | -54.14 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | 2.88 Mn |
| Mar 31, 2024 | 2.88 Mn |
| Dec 31, 2023 | -2.50 Mn |
| Dec 31, 2023 | -2.50 Mn |